Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study-Reference-Cited by-同舟云学术

Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study

Published:2023-01 Issue: Volume:87 Page:104414
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Cognasse Fabrice,Hamzeh-Cognasse Hind,Rosa Mickael,Corseaux Delphine^ORCID,Bonneaudeau Brigitte,Pierre Chloe,Huet Julie,Arthaud Charles Antoine,Eyraud Marie Ange,Prier Amélie,Duchez Anne Claire,Ebermeyer Theo,Heestermans Marco,Audoux-Caire Estelle,Philippot Quentin,Le Voyer Tom,Hequet Olivier,Fillet Anne-Marie,Chavarin Patricia,Legrand Dominique,Richard Pascale,Pirenne France,Gallian Pierre,Casanova Jean Laurent,Susen Sophie,Morel Pascal,Lacombe Karine,Bastard Paul,Tiberghien Pierre

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference83 articles.

1. The convalescent sera option for containing COVID-19;Casadevall;J Clin Invest,2020

2. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant;O'Shaughnessy;Br J Haematol,2004

3. Transfusion in critically ill children: indications, risks, and challenges;Parker;Crit Care Med,2014

4. Fresh frozen plasma transfusion in critically ill medical patients with coagulopathy;Dara;Crit Care Med,2005

5. Transfusion-related acute lung injury;Cho,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of COVID‐19 convalescent plasma: A definitive systematic review and meta‐analysis of randomized controlled trials;Transfusion;2023-12-29

2. Passive antibody therapy in emerging infectious diseases;Frontiers of Medicine;2023-12-02

3. Prolonged SARS-CoV-2 Infection in Patients Receiving Anti-CD20 Monoclonal Antibodies: A Diagnostic Challenged by Negative Nasopharyngeal RT-PCR and Successful Treatment with COVID-19 High-Titer Convalescent Plasma;Viruses;2023-11-07

4. Is there any revival of the use of plasma therapy or neutralizing convalescent antibody therapy to treat SARS-CoV-2 variants and are we rethinking preparedness plans?;Transfusion and Apheresis Science;2023-06

5. Redefining Lobe-Wise Ground-Glass Opacity in COVID-19 Through Deep Learning and its Correlation With Biochemical Parameters;IEEE Journal of Biomedical and Health Informatics;2023-06